Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 3
Submit an article Journal homepage
186
Views
20
CrossRef citations to date
0
Altmetric
Review

Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer

Darren D Browning Medical College of Georgia, Department of Biochemistry and Molecular Biology, 1120 15th Street, CB2605, Augusta, GA 30912-2100, USA +1 706 721 9526; +1 706 721 6608; [email protected]
Pages 367-376 | Published online: 13 Feb 2008

Bibliography

  • He AR, Marshall J. Biologic therapy for colon cancer. Clin Adv Hematol Oncol 2005;3:555-61
  • Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007;57:168-85
  • Chung KY, Saltz LB. Adjuvant therapy of colon cancer: current status and future directions. Cancer J 2007;13:192-7
  • Carrithers SL. Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer? Proc Natl Acad Sci USA 2003;100:3018-20
  • Pitari GM, Zingman LV, Hodgson DM, et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 2003;100:2695-9
  • Uzzau S, Fasano A. Cross-talk between enteric pathogens and the intestine. Cell Microbiol 2000;2:83-9
  • Kazerounian S, Pitari GM, Shah FJ, et al. Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins. J Pharmacol Exp Ther 2005;314:1013-22
  • Pitari GM, Baksh RI, Harris DM, et al. Interruption of homologous desensitization in cyclic guanosine 3′,5′-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins. Cancer Res 2005;65:11129-35
  • Liu L, Li H, Underwood T, et al. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther 2001;299:583-92
  • Deguchi A, Thompson WJ, Weinstein IB. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 2004;64:3966-73
  • Zhu B, Vemavarapu L, Thompson WJ, Strada SJ. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells. J Cell Biochem 2005;94:336-50
  • Lohmann SM, Walter U. Tracking functions of cGMP-dependent protein kinases (cGK). Front Biosci 2005;10:1313-28
  • Ruth P. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol Ther 1999;82:355-72
  • Lincoln TM, Dey N, Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 2001;91:1421-30
  • Francis SH, Corbin JD. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci 1999;36:275-328
  • Hou Y, Gupta N, Schoenlein P, et al. An anti-tumor role for cGMP-dependent protein kinase. Cancer Lett 2006;240:60-8
  • Kwon I-K, Schoenlein PV, Delk J, et al. Expression of PKG in metastatic colon carcinoma cells blocks tumor angiogenesis. Cancer 2008; In Press
  • Orstavik S, Natarajan V, Tasken K, et al. Characterization of the human gene encoding the type Iα and type Iβ cGMP-dependent protein kinase (PRKG1). Genomics 1997;42:311-8
  • Orstavik S, Solberg R, Tasken K, et al. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase. Biochem Biophys Res Commun 1996;220:759-65
  • Forte LR, London RM, Krause WJ, Freeman RH. Mechanisms of guanylin action via cyclic GMP in the kidney. Ann Rev Physiol 2000;62:673-95
  • Cornwell TL, Lincoln TM. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 1989;264:1146-55
  • Draijer R, Vaandrager AB, Nolte C, et al. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 1995;77:897-905
  • Fischer TA, Palmetshofer A, Gambaryan S, et al. Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J Biol Chem 2001;276:5967-74
  • Vaandrager AB, Tilly BC, Smolenski A, et al. cGMP stimulation of cystic fibrosis transmembrane conductance regulator Cl– channels co-expressed with cGMP-dependent protein kinase type II but not type Iβ. J Biol Chem 1997;272:4195-200
  • Lin G, Chow S, Lin J, et al. Effect of cell passage and density on protein kinase G expression and activation in vascular smooth muscle cells. J Cell Biochem 2004;92:104-12
  • Wong AS, Kim SO, Leung PC, et al. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium. Gynecol Oncol 2001;82:305-11
  • Silberbach M, Roberts CT Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 2001;13:221-31
  • Lincoln TM, Cornwell TL, Komalavilas P, Boerth N. Cyclic GMP-dependent protein kinase in nitric oxide signaling. Methods Enzymol 1996;269:149-66
  • Smolenski A, Burkhardt AM, Eigenthaler M, et al. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch Pharmacol 1998;358:134-9
  • Hofmann F, Ammendola A, Schlossmann J. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 2000;113:1671-6
  • Pilz RB, Broderick KE. Role of cyclic GMP in gene regulation. Front Biosci 2005;10:1239-68
  • Lincoln TM, Wu X, Sellak H, et al. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 2006;11:356-67
  • Fiedler B, Lohmann SM, Smolenski A, et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:11363-8
  • Shimojo T, Hiroe M, Ishiyama S, et al. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res 1999;247:38-47
  • Segawa K, Minami K, Shiga Y, et al. Inhibitory effects of nicorandil on rat mesangial cell proliferation via the protein kinase G pathway. Nephron 2001;87:263-8
  • Loweth AC, Williams GT, Scarpello JH, Morgan NG. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett 1997;400:285-8
  • Brunetti M, Mascetra N, Manarini S, et al. Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis. Biochem Biophys Res Commun 2002;297:498-501
  • Takuma K, Phuagphong P, Lee E, et al. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem 2001;276:48093-9
  • Kim YM, Chung HT, Kim SS, et al. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 1999;19:6740-7
  • Komalavilas P, Shah PK, Jo H, Lincoln TM. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 1999;274:34301-9
  • Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998;273:23504-8
  • Piazza GA, Thompson WJ, Pamukcu R, et al. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res 2001;61:3961-8
  • Joe AK, Liu H, Xiao D, et al. Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells. J Exp Ther Oncol 2003;3:83-94
  • Webster WS, Leibovich BC. Exisulind in the treatment of prostate cancer. Expert Rev Anticancer Ther 2005;5:957-62
  • Han EK, Arber N, Yamamoto H, et al. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 1998;48:195-203
  • Chan DC, Earle KA, Zhao TL, et al. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res 2002;8:904-12
  • Goluboff ET. Exisulind, a selective apoptotic antineoplastic drug. Expert Opin Investig Drugs 2001;10:1875-82
  • Thompson WJ, Piazza GA, Li H, et al. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 2000;60:3338-42
  • Huang Y, He Q, Hillman MJ, et al. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res 2001;61:6918-24
  • Soh JW, Mao Y, Kim MG, et al. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res 2000;6:4136-41
  • Soh JW, Mao Y, Liu L, et al. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J Biol Chem 2001;276:16406-10
  • Browning DD, McShane MP, Marty C, Ye RD. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J Biol Chem 2000;275:2811-6
  • Browning DD, Windes ND, Ye RD. Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J Biol Chem 1999;274:537-42
  • Komalavilas P, Shah PK, Jo H, Lincoln TM. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 1999;274:34301-9
  • Pitari GM, Li T, Baksh RI, Waldman SA. Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells. Mol Cancer Ther 2006;5:1190-6
  • Pitari GM, Di Guglielmo MD, Park J, et al. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 2001;98:7846-51
  • Saha S, Chowdhury P, Pal A, Chakrabarti MK. Downregulation of human colon carcinoma cell (COLO-205) proliferation through PKG-MAP kinase mediated signaling cascade by E. coli heat stable enterotoxin (STa), a potent anti-angiogenic and anti-metastatic molecule. J Appl Toxicol 2007; published online 10 Sep 2007:doi.10.1002/jat.1297
  • Suhasini M, Li H, Lohmann SM, et al. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway. Mol Cell Biol 1998;18:6983-94
  • Grossmann J. Molecular mechanisms of “detachment-induced apoptosis-Anoikis”. Apoptosis 2002;7:247-60
  • Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-62
  • Shanmugathasan M, Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 2000;50:273-9
  • Hou Y, Wong E, Martin J, et al. A role for cyclic-GMP dependent protein kinase in anoikis. Cell Signal 2006;18:882-8
  • Whittard JD, Akiyama SK. Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A. J Cell Sci 2001;114:3265-72
  • Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997;9:701-6
  • Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-8
  • Liu K, Li L, Nisson PE, et al. Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol 1999;19:3696-703
  • Krause M, Dent EW, Bear JE, et al. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Ann Rev Cell Dev Biol 2003;19:541-64
  • Howe AK, Juliano RL. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat Cell Biol 2000;2:593-600
  • Howe AK, Hogan BP, Juliano RL. Regulation of vasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion. J Biol Chem 2002;277:38121-6
  • Lambrechts AI, Kwiatkowski A, Lanier LM, et al. PKA phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3-domains. J Biol Chem 2000;275:36143-51
  • Ball LJ, Kuhne R, Hoffmann B, et al. Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J 2000;19:4903-14
  • Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000;36:1607-20
  • Birchmeier W, Hulsken J, Behrens J. Adherens junction proteins in tumour progression. Cancer Surv 1995;24:129-40
  • Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91
  • Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 2000;100:209-19
  • Browning DD, McShane M, Marty C, Ye RD. Functional analysis of type 1α cGMP-dependent protein kinase using green fluorescent fusion proteins. J Biol Chem 2001;276:13039-48
  • Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, et al. Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006;290:L919-30
  • Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999;18(1):15-30
  • Bienz M. The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 2002;3:328-38
  • Lilien J, Balsamo J, Arregui C, Xu G. Turn-off, drop-out: functional state switching of cadherins. Dev Dyn 2002;224:18-29
  • Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004;303:1483-7
  • Harris TJ, Peifer M. Decisions, decisions: β-catenin chooses between adhesion and transcription. Trends Cell Biol 2005;15:234-7
  • Brembeck FH, Schwarz-Romond T, Bakkers J, et al. Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions. Genes Dev 2004;18:2225-30
  • Castano J, Raurell I, Piedra JA, et al. Beta-catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin. J Biol Chem 2002;277:31541-50
  • Huber AH, Weis WI. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 2001;105:391-402
  • Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of β-catenin. Curr Opin Cell Biol 2005;17:459-65
  • Piedra J, Martinez D, Castano J, et al. Regulation of β-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 2001;276:20436-43
  • Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977;59:221-6
  • Gagos S, Hopwood VL, Iliopoulos D, et al. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Res 1995;15:369-78
  • Sund M, Zeisberg M, Kalluri R. Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application. Gastroenterology 2005;129:2076-91
  • Van Es JH, Barker N, Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003;13:28-33
  • Easwaran V, Lee SH, Inge L, et al. β-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003;63:3145-53
  • Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001;61:6050-4
  • Giles RH, Van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24
  • Behrens J. Control of β-catenin signaling in tumor development. Ann NY Acad Sci 2000;910:21-33; discussion 25-33
  • Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003;129:199-221
  • Hanson CA, Miller JR. Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein. Gene 2005;361:1-12
  • Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control 2005;16:201-13
  • Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-70
  • Blom N, Sicheritz-Ponten T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004;4:1633-49
  • Taurin S, Sandbo N, Qin Y, et al. Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase. J Biol Chem 2006;281:9971-6
  • Orford K, Orford CC, Byers SW. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 1999;146:855-68
  • Veeramachaneni NK, Kubokura H, Lin L, et al. Down-regulation of β-catenin inhibits the growth of esophageal carcinoma cells. J Thorac Cardiovasc Surg 2004;127:92-8
  • Green DW, Roh H, Pippin JA, Drebin JA. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. J Surg Res 2001;101:16-20
  • Roh H, Green DW, Boswell CB, et al. Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res 2001;61:6563-8
  • Kim JW, Gao P, Liu YC, et al. HIF-1 and dysregulated c-Myc cooperatively induces VEGF and metabolic switches, HK2 and PDK1. Mol Cell Biol 2007; published online 4 September 2007, doi:10.1128/MCB.00440-07
  • Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006;38:1060-5
  • Ngo CV, Gee M, Akhtar N, et al. An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. Cell Growth Differ 2000;11:201-10
  • Van De Wetering M, Oving I, Muncan V, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003;4:609-15
  • Forte LR Jr. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Ther 2004;104:137-62
  • Shailubhai K, Yu HH, Karunanandaa K, et al. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 2000;60:5151-7
  • Takahashi-Yanaga F, Sasaguri T. The Wnt/β-catenin signaling pathway as a target in drug discovery. J Pharmacol Sci 2007;104:293-302
  • Luu HH, Zhang R, Haydon RC, et al. Wnt/β-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004;4:653-71
  • Bell EN, Tse MY, Frederiksen LJ, et al. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells. J Urol 2007;177:751-6
  • Frederiksen LJ, Sullivan R, Maxwell LR, et al. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 2007;13:2199-206
  • Rigas B, Kashfi K. Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol Med 2004;10:324-30
  • Nath N, Kashfi K, Chen J, Rigas B. Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association. Proc Natl Acad Sci USA 2003;100:12584-9
  • Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol 2006;147(Suppl 1):S252-7
  • Guerrant RL, Hughes JM, Chang B, et al. Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. J Infect Dis 1980;142:220-8
  • Rao MC, Guandalini S, Smith PL, Field M. Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP. Biochim Biophys Acta 1980;632:35-46
  • Waldman SA, Cagir B, Rakinic J, et al. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer. Dis Colon Rectum 1998;41:310-5
  • Cagir B, Gelmann A, Park J, et al. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 1999;131:805-12
  • Almenoff JS, Williams SI, Scheving LA, et al. Ligand-based histochemical localization and capture of cells expressing heat-stable enterotoxin receptors. Mol Microbiol 1993;8:865-73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.